Wendy Kampman

3.1k total citations · 1 hit paper
8 papers, 903 citations indexed

About

Wendy Kampman is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Wendy Kampman has authored 8 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Genetics and 2 papers in Surgery. Recurrent topics in Wendy Kampman's work include Microscopic Colitis (4 papers), Inflammatory Bowel Disease (4 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Wendy Kampman is often cited by papers focused on Microscopic Colitis (4 papers), Inflammatory Bowel Disease (4 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Wendy Kampman collaborates with scholars based in United States, Netherlands and Germany. Wendy Kampman's co-authors include Laurent Peyrin‐Biroulet, Aude Bressenot, Stefanie Schreiber, Daniël W. Hommes, G. D’Haens, Roopal Thakkar, A. Lazar, B Huang, Walter Reinisch and Remo Panaccione and has published in prestigious journals such as Clinical Infectious Diseases, Gut and Annals of the Rheumatic Diseases.

In The Last Decade

Wendy Kampman

8 papers receiving 875 citations

Hit Papers

Adalimumab for induction of clinical remission in moderat... 2011 2026 2016 2021 2011 200 400 600

Peers

Wendy Kampman
B Huang Canada
Hanzhe Zheng United States
G. D’Haens Netherlands
Richard A. Lirio United States
Fred Princen United States
Vipin Arora United States
Yinghua Lang United States
B Huang Canada
Wendy Kampman
Citations per year, relative to Wendy Kampman Wendy Kampman (= 1×) peers B Huang

Countries citing papers authored by Wendy Kampman

Since Specialization
Citations

This map shows the geographic impact of Wendy Kampman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Kampman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Kampman more than expected).

Fields of papers citing papers by Wendy Kampman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Kampman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Kampman. The network helps show where Wendy Kampman may publish in the future.

Co-authorship network of co-authors of Wendy Kampman

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Kampman. A scholar is included among the top collaborators of Wendy Kampman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Kampman. Wendy Kampman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Stein, David, Ernesto Oviedo‐Orta, Wendy Kampman, et al.. (2021). Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders. Clinical Infectious Diseases. 75(1). e509–e515. 7 indexed citations
2.
Lowenstern, Angela, Shuang Li, Ann Marie Návar, et al.. (2021). Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry. Clinical Cardiology. 44(6). 863–870. 3 indexed citations
3.
Genovese, M. C., Hubert van Hoogstraten, Wendy Kampman, Shyamalie Jayawardena, & T. Huizinga. (2017). FRI0242 Association between clinical and radiographic responses, and physical function in a phase 3 study of sarilumab plus methotrexate in patients with active, moderate-to-severe rheumatoid arthritis. Annals of the Rheumatic Diseases. 76. 576–577. 2 indexed citations
4.
Peyrin‐Biroulet, Laurent, Aude Bressenot, & Wendy Kampman. (2013). Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?. Clinical Gastroenterology and Hepatology. 12(6). 929–934.e2. 163 indexed citations
5.
Reinisch, Walter, William J. Sandborn, Daniël W. Hommes, et al.. (2011). Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 60(6). 780–787. 683 indexed citations breakdown →
6.
Saurat, J.‐H., Richard G. Langley, Kristian Reich, et al.. (2011). Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study. British Journal of Dermatology. 165(2). 399–406. 41 indexed citations
7.
Reinisch, Walter, William J. Sandborn, Daniël W. Hommes, et al.. (2011). Effect of adalimumab induction therapy on clinical laboratory parameters suggesting improved nutrition and inflammation status in patients with moderately to severely active ulcerative colitis.. Inflammatory Bowel Diseases. 17(suppl_1). S58–S59. 2 indexed citations
8.
Reinisch, Walter, William J. Sandborn, Daan W. Hommes, et al.. (2010). Effect of Adalimumab Induction Therapy on Clinical Laboratory Parameters Suggesting Improved Nutrition and Inflammation Status in Patients with Moderately to Severely Active Ulcerative Colitis. The American Journal of Gastroenterology. 105. S428–S429. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026